Validation and application of a module of the M. D. Anderson Symptom Inventory for measuring multiple symptoms in patients with gastrointestinal cancer (the MDASI‐GI)
Tóm tắt
Từ khóa
Tài liệu tham khảo
Borden EC, 1998, A perspective on the clinical effectiveness and tolerance of interferon‐alpha, Semin Oncol., 25, 3
US Food and Drug Administration. Guidelines for Industry. Patient‐Reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims. Available at:http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM071975.pdfAccessed February 1 2010.
Dodd MJ, 2005, Advancing our knowledge of symptom clusters, J Support Oncol., 3, 30
Parse RR, 1985, Nursing Research: Qualitative Methods, 91
Sloan JA, 2003, Detecting worms, ducks and elephants: a simple approach for defining clinically relevant effects in quality‐of‐life measures, J Cancer Integrative Med., 1, 41
Gorsuch RL, 1983, Factor Analysis
Mulaik SA, 1971, The Foundations of Factor Analysis
Cleeland CS, 1994, Pain assessment: global use of the Brief Pain Inventory, Ann Acad Med Singapore, 23, 129
SPSS, Inc, 2006, Statistical Package for the Social Sciences, version 15.0 [computer program]
MendozaTR AndersonKO WangXS EasleyM MobleyG CleelandCS.Phone it in or fill it in? Comparing symptom assessment using the interactive voice response system with the traditional paper and pencil method. Paper presented at: International Society for Quality of Life Research 8th Annual Conference Amsterdam the Netherlands November7‐10 2001.
Wang XS, 2009, Association of sTNF‐R1 and the development of treatment‐related symptoms in patients undergoing concurrent chemoradiation therapy for colorectal or esophageal cancer [abstract], J Clin Oncol., 27